×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MRNA – moderna, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MRNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
08:30 am
mrna
Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Berenberg Bank. They set a "hold" rating and a $42.00 price target on the stock.
Medium
Report
Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Berenberg Bank. They set a "hold" rating and a $42.00 price target on the stock.
11/19
06:22 am
mrna
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Medium
Report
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
11/18
12:36 pm
mrna
Moderna, Inc. (NASDAQ: MRNA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $69.00 price target on the stock, down previously from $115.00.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $69.00 price target on the stock, down previously from $115.00.
11/18
08:07 am
mrna
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $58.00 price target on the stock.
Medium
Report
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $58.00 price target on the stock.
11/15
05:43 pm
mrna
Moderna, Inc. (MRNA) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript) [Seeking Alpha]
Medium
Report
Moderna, Inc. (MRNA) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript) [Seeking Alpha]
11/12
08:15 am
mrna
Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year
Low
Report
Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year
11/8
02:32 pm
mrna
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Barclays PLC from $125.00 to $111.00. They now have an "overweight" rating on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Barclays PLC from $125.00 to $111.00. They now have an "overweight" rating on the stock.
11/8
10:59 am
mrna
Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Low
Report
Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
04:15 pm
mrna
Form 4 Moderna, Inc. For: Nov 08 Filed by: Hoge Stephen
Medium
Report
Form 4 Moderna, Inc. For: Nov 08 Filed by: Hoge Stephen
11/12
09:33 am
mrna
Form 144 Moderna, Inc. Filed by: Hoge Stephen
Low
Report
Form 144 Moderna, Inc. Filed by: Hoge Stephen
11/7
04:04 pm
mrna
Form 10-Q Moderna, Inc. For: Sep 30
Medium
Report
Form 10-Q Moderna, Inc. For: Sep 30
11/7
06:36 am
mrna
Form 8-K Moderna, Inc. For: Nov 07
Medium
Report
Form 8-K Moderna, Inc. For: Nov 07
10/8
04:20 pm
mrna
Form 4 Moderna, Inc. For: Oct 04 Filed by: Mock James M
Low
Report
Form 4 Moderna, Inc. For: Oct 04 Filed by: Mock James M
10/7
03:21 pm
mrna
Form 144 Moderna, Inc. Filed by: Mock James M
Low
Report
Form 144 Moderna, Inc. Filed by: Mock James M
10/4
08:53 am
mrna
Form 4 Moderna, Inc. For: Oct 02 Filed by: Hussain Abbas
Low
Report
Form 4 Moderna, Inc. For: Oct 02 Filed by: Hussain Abbas
10/4
08:50 am
mrna
Form 3 Moderna, Inc. For: Oct 02 Filed by: Hussain Abbas
Low
Report
Form 3 Moderna, Inc. For: Oct 02 Filed by: Hussain Abbas
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Germany's CureVac says low-dose coronavirus vaccine could allow for mass production [Yahoo! Finance News]
28.0%
2/24 Form 4 Moderna, Inc. For: Feb 20 Filed by: Bancel Stephane 27.8%
4/16 Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus 21.3%
2/25 Form 4 Moderna, Inc. For: Feb 24 Filed by: Hoge Stephen 19.8%
3/17 Form 4 Moderna, Inc. For: Mar 13 Filed by: Bancel Stephane 16.7%
2/28 A Big Coronavirus Mystery: Where Are The Children? [zero hedge] 14.4%
4/19 4 Top Stock Trades for Monday: BA, MRNA, SLB, KSU [Yahoo! Finance News] 12.6%
4/1 White House advisor Fauci says coronavirus vaccine trial is on target and will be 'ultimate game changer' [CNBC] 12.2%
4/15 Coronavirus updates: Trump says states will decide when to reopen [CBS News] 9.2%
3/25 Moderna to Present at MIT Lecture Series 9.2%
2/24 Form 4 Moderna, Inc. For: Feb 20 Filed by: Bancel Stephane 27.8%
4/16 Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus 21.3%
2/25 Form 4 Moderna, Inc. For: Feb 24 Filed by: Hoge Stephen 19.8%
3/17 Form 4 Moderna, Inc. For: Mar 13 Filed by: Bancel Stephane 16.7%
2/28 A Big Coronavirus Mystery: Where Are The Children? [zero hedge] 14.4%
4/19 4 Top Stock Trades for Monday: BA, MRNA, SLB, KSU [Yahoo! Finance News] 12.6%
4/1 White House advisor Fauci says coronavirus vaccine trial is on target and will be 'ultimate game changer' [CNBC] 12.2%
4/15 Coronavirus updates: Trump says states will decide when to reopen [CBS News] 9.2%
3/25 Moderna to Present at MIT Lecture Series 9.2%
TOP News Decliners
2/26
Trump says U.S. ‘very ready’ for coronavirus; Mike Pence to lead response [Toronto Globe and Mail (Ontario, Canada)]
-20.7%
3/6 Form 4 Moderna, Inc. For: Mar 04 Filed by: Kim Lorence H. -17.9%
3/19 Here are 3 drugs in development to fight coronavirus, 2 vaccines and one 'passive' vaccine [DailyFinance (AOL.com)] -14.3%
1/9 Moderna +16% on positive CMV vaccine data [Seeking Alpha] -13.0%
3/10 7 Stocks Poised to Profit From Coronavirus [Yahoo! Finance News] -11.5%
2/11 Form SC 13G Moderna, Inc. Filed by: VANGUARD GROUP INC -10.8%
5/7 Form 8-K Moderna, Inc. For: May 07 -9.4%
3/23 Form 8-K Moderna, Inc. For: Mar 23 -8.9%
4/27 Moderna submits IND application for Phase 2 COVID-19 study [Seeking Alpha] -8.5%
1/28 US health officials fast-track coronavirus vaccine, hope to start clinical trial in three months [MSNBC.com] -8.1%
3/6 Form 4 Moderna, Inc. For: Mar 04 Filed by: Kim Lorence H. -17.9%
3/19 Here are 3 drugs in development to fight coronavirus, 2 vaccines and one 'passive' vaccine [DailyFinance (AOL.com)] -14.3%
1/9 Moderna +16% on positive CMV vaccine data [Seeking Alpha] -13.0%
3/10 7 Stocks Poised to Profit From Coronavirus [Yahoo! Finance News] -11.5%
2/11 Form SC 13G Moderna, Inc. Filed by: VANGUARD GROUP INC -10.8%
5/7 Form 8-K Moderna, Inc. For: May 07 -9.4%
3/23 Form 8-K Moderna, Inc. For: Mar 23 -8.9%
4/27 Moderna submits IND application for Phase 2 COVID-19 study [Seeking Alpha] -8.5%
1/28 US health officials fast-track coronavirus vaccine, hope to start clinical trial in three months [MSNBC.com] -8.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: